Midazolam prevents the adverse outcome of neonatal asphyxia.
Björn GailusRicardo SchmidtMarie JohneWolfgang LöscherPublished in: Annals of neurology (2022)
The disease-modifying effect of midazolam identified here strongly suggests that this drug provides a valuable option for improving the treatment and outcome of BA. This article is protected by copyright. All rights reserved.